Acquisition of Boston biotech for up to $120M a 'validation' of Ora's model

The CEO of Andover-based contract research organization Ora said the planned acquisition for up to $120 million of a Boston-based biotech firm he spun out seven years ago is validation of the company’s model for drug development...